PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
329 hedge funds and large institutions have $6.24B invested in PRA Health Sciences, Inc. in 2019 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 146 increasing their positions, 94 reducing their positions, and 43 closing their positions.
109% more call options, than puts
Call options by funds: $22.5M | Put options by funds: $10.8M
55% more repeat investments, than reductions
Existing positions increased: 146 | Existing positions reduced: 94
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
5% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 43
0.27% more ownership
Funds ownership: 99.94% → 100.21% (+0.27%)
0% more funds holding
Funds holding: 329 → 329 (0)
4% less capital invested
Capital invested by funds: $6.49B → $6.24B (-$244M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$171M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$166M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$120M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$118M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$99.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$664M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$147M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$90.9M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$71.5M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$62.3M |
PRAH Hedge Fund Activity: Q3 2019 in Review
329 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q3 2019, worth a combined $6.24B — down 3.8% from $6.49B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new PRAH positions and 43 closed out — a net gain of 2 holders — while 146 added to existing stakes and 94 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $171M. The largest seller was Kohlberg Kravis Roberts & Co, exiting entirely with an estimated $664M sold.
- 329 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $6.24B of PRA Health Sciences, Inc. stock for Q3 2019, down 3.8% quarter-over-quarter.
- 45 funds opened new PRA Health Sciences, Inc. positions in Q3 2019 and 43 closed out, a net change of +2 holders.
- The largest PRA Health Sciences, Inc. buyer in Q3 2019 was Janus Henderson Group, an estimated $171M added.
- The largest PRA Health Sciences, Inc. seller in Q3 2019 was Kohlberg Kravis Roberts & Co, an estimated $664M sold.
Based on aggregated 13F filings for Q3 2019.